Bioethics News

Cuban-Developed Lung Cancer Vaccine Could Arrive in US

May 13, 2015

(ABC News) – As U.S. relations with Cuba thaw, one unexpected byproduct could be the introduction of a Cuban-developed lung cancer vaccine in the U.S. Called Cimavax, an innovative vaccine that was developed to help treat lung cancer patients in Cuba, where lung cancer is one of the leading causes of death. The immunotherapy treatment could be coming to the U.S. thanks in part to the Roswell Park Cancer Institute in Buffalo, New York, which is working with Cuba’s Center for Molecular Immunology to bring the treatment to the U.S.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.